V
Dexcom just got FDA clearance for an OTC glucose sensor.
Usually, the health tech I see at CES is vaporware, but good news! Dexcom’s Stelo continuous glucose biosensor just got FDA clearance, making it the first ever to not require a prescription. Stelo is meant to help folks with Type 2 diabetes who don’t use insulin better manage their condition.
It’ll be available starting this summer. We still don’t know pricing, but when I spoke with Dexcom in January they said it was meant to be an affordable.
Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates.
Loading comments
Getting the conversation ready...
Most Popular
Most Popular
- Apple’s weird anti-nausea dots cured my car sickness
- Apple’s smart home camera service is starting to impress me
- Tim Cook says RAM expenses are ‘unsustainable’ and Apple is going to raise prices
- Can anyone look cool wearing Snap’s $2,000 glasses?
- Snap is finally about to ship AR glasses — and they cost a fortune
